CALLICUTT JACK W

CIK 00012667733 companiesNORCROSS, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001266773

Recent Transactions

50 trades

Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+65,000→ 65,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-16+100,000→ 100,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-06$3.67/sh−20,354→ 7,614 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-05$3.90/sh−25,732→ 27,968 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02+60,000→ 67,614 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02$4.20/sh−13,914→ 53,700 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-01−60,000→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-18$6.22/sh−18,210→ 7,614 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-18$6.22/sh−28,100→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-18$1.11/sh+18,210→ 25,824 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-18−28,120→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-18$1.98/sh+28,100→ 35,714 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock (right to buy)
2025-11-18−18,190→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$6.03/sh−9,586→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-17−9,586→ 28,120 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$1.23/sh+2,323→ 9,937 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-17−19,701→ 18,190 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$6.03/sh−19,701→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$1.11/sh+19,701→ 27,315 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-17−2,323→ 48,750 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$6.03/sh−2,323→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-17$1.98/sh+9,586→ 17,200 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$6.03/sh−1,736→ 7,614 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$6.03/sh−1,675→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$1.11/sh+1,675→ 9,289 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$1.23/sh+1,736→ 9,350 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-10−1,880→ 37,706 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-10−1,736→ 51,073 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$6.02/sh−1,880→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-10−1,675→ 37,891 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-10$1.98/sh+1,880→ 9,694 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$6.00/sh−200→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$1.98/sh+200→ 7,814 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$6.00/sh−200→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$1.72/sh+200→ 7,814 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-05−200→ 39,586 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-05−200→ 39,566 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$1.11/sh+200→ 7,814 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-05−200→ 52,809 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-05$6.00/sh−200→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-04−10,741→ 53,009 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$1.11/sh+8,974→ 16,588 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-04−8,974→ 39,766 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$6.07/sh−10,741→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-04−8,914→ 39,786 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$1.98/sh+8,914→ 16,528 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$6.07/sh−8,914→ 7,614 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$1.72/sh+10,741→ 18,355 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-04$6.07/sh−8,974→ 7,614 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-03$6.01/sh−1,300→ 7,614 total

Companies

Recent Filings

Address

C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240

NORCROSS, GA, 30071

View on SEC.gov